BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10625611)

  • 1. The role of Glu(192) in the allosteric control of the S(2)' and S(3)' subsites of thrombin.
    Marque PE; Spuntarelli R; Juliano L; Aiach M; Le Bonniec BF
    J Biol Chem; 2000 Jan; 275(2):809-16. PubMed ID: 10625611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin enhances the catalytic activity of des-ETW-thrombin.
    Goodwin CA; Deadman JJ; Le Bonniec BF; Elgendy S; Kakkar VV; Scully MF
    Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):77-83. PubMed ID: 8670135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric changes of thrombin catalytic site induced by interaction of bothrojaracin with anion-binding exosites I and II.
    Monteiro RQ; Rapôso JG; Wisner A; Guimarães JA; Bon C; Zingali RB
    Biochem Biophys Res Commun; 1999 Sep; 262(3):819-22. PubMed ID: 10471408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of exosite occupancy on the substrate specificity of thrombin.
    Ng NM; Quinsey NS; Matthews AY; Kaiserman D; Wijeyewickrema LC; Bird PI; Thompson PE; Pike RN
    Arch Biochem Biophys; 2009 Sep; 489(1-2):48-54. PubMed ID: 19638274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidation of the structural basis for the slow reactivity of thrombin with plasminogen activator inhibitor-1.
    Rezaie AR
    Biochemistry; 1998 Sep; 37(38):13138-42. PubMed ID: 9748320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of the catalytic groove preferences of factor Xa reveals an inadequate selectivity for its macromolecule substrates.
    Bianchini EP; Louvain VB; Marque PE; Juliano MA; Juliano L; Le Bonniec BF
    J Biol Chem; 2002 Jun; 277(23):20527-34. PubMed ID: 11925440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the P2' and P3' specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis.
    Le Bonniec BF; Myles T; Johnson T; Knight CG; Tapparelli C; Stone SR
    Biochemistry; 1996 Jun; 35(22):7114-22. PubMed ID: 8679538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of exosite ligands to human thrombin. Re-evaluation of allosteric linkage between thrombin exosites I and II.
    Verhamme IM; Olson ST; Tollefsen DM; Bock PE
    J Biol Chem; 2002 Mar; 277(9):6788-98. PubMed ID: 11724802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrostatic steering and ionic tethering in the formation of thrombin-hirudin complexes: the role of the thrombin anion-binding exosite-I.
    Myles T; Le Bonniec BF; Betz A; Stone SR
    Biochemistry; 2001 Apr; 40(16):4972-9. PubMed ID: 11305913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of allosteric linkage between the sodium ion binding site and exosite I of thrombin during prothrombin activation.
    Kroh HK; Tans G; Nicolaes GA; Rosing J; Bock PE
    J Biol Chem; 2007 Jun; 282(22):16095-104. PubMed ID: 17430903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the insertion loop around tryptophan 148 in tthe activity of thrombin.
    DiBella EE; Scheraga HA
    Biochemistry; 1996 Apr; 35(14):4427-33. PubMed ID: 8605192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of glutamic acid 192 to glutamine in activated protein C changes the substrate specificity and increases reactivity toward macromolecular inhibitors.
    Rezaie AR; Esmon CT
    J Biol Chem; 1993 Sep; 268(27):19943-8. PubMed ID: 8104182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermodynamic investigation of hirudin binding to the slow and fast forms of thrombin: evidence for folding transitions in the inhibitor and protease coupled to binding.
    Ayala YM; Vindigni A; Nayal M; Spolar RS; Record MT; Di Cera E
    J Mol Biol; 1995 Nov; 253(5):787-98. PubMed ID: 7473752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the hirudin-thrombin interaction by incorporation of noncoded amino acids and molecular dynamics simulation.
    De Filippis V; Colombo G; Russo I; Spadari B; Fontana A
    Biochemistry; 2002 Nov; 41(46):13556-69. PubMed ID: 12427016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric modulation of the activity of thrombin.
    Duffy EJ; Angliker H; Le Bonniec BF; Stone SR
    Biochem J; 1997 Jan; 321 ( Pt 2)(Pt 2):361-5. PubMed ID: 9020867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen gamma' chain binds thrombin exosite II.
    Lovely RS; Moaddel M; Farrell DH
    J Thromb Haemost; 2003 Jan; 1(1):124-31. PubMed ID: 12871549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple inhibitory kinetics reveal an allosteric interplay among thrombin functional sites.
    Zavyalova E; Kopylov A
    Thromb Res; 2015 Jan; 135(1):212-6. PubMed ID: 25467079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of exosites 1 and 2 in thrombin reaction with plasminogen activator inhibitor-1 in the absence and presence of cofactors.
    Rezaie AR
    Biochemistry; 1999 Nov; 38(44):14592-9. PubMed ID: 10545182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glu-192----Gln substitution in thrombin mimics the catalytic switch induced by thrombomodulin.
    Le Bonniec BF; Esmon CT
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7371-5. PubMed ID: 1678522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
    Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
    J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.